UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008626 |
|---|---|
| Receipt number | R000010136 |
| Scientific Title | Phase II trial of Trastuzumab + CPT-11 therapy for HER2-positive advanced gastric cancer patients with prior chemotherapy |
| Date of disclosure of the study information | 2012/08/06 |
| Last modified on | 2020/01/22 22:20:20 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/08/05 23:15:19 | ||
| 2 | Update | 2012/09/23 16:08:44 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 3 | Update | 2013/08/05 22:35:29 | Anticipated trial start date |
|
| 4 | Update | 2014/09/05 22:09:51 | Email Institutions |
|
| 5 | Update | 2015/02/05 22:52:42 | Recruitment status Last follow-up date |
|
| 6 | Update | 2015/06/10 00:52:44 | Email |
|
| 7 | Update | 2016/10/19 22:57:16 | Name of primary person or sponsor Organization |
|
| 8 | Update | 2017/09/04 07:17:46 | Recruitment status |
|
| 9 | Update | 2018/04/30 23:47:20 | Email |
|
| 10 | Update | 2018/05/10 20:32:44 | Email |
|
| 11 | Update | 2020/01/05 19:41:57 | Date of IRB Date analysis concluded |
|
| 12 | Update | 2020/01/05 19:49:40 | URL releasing protocol Number of participants that the trial has enrolled Results Delayed Results Delay Reason Results Delay Reason |
|
| 13 | Update | 2020/01/22 22:20:20 | Date of IRB |
